September 19th- Prof. Samir Parekh- Targeted Therapy of CAR+ T-Cell Lymphoma after Anti-BCMA CAR T-Cell Therapy

September 10th- Dr. Bruno Paiva- Ultrasensitive detection of circulating multiple myeloma cells by next-generation flow after immunomagnetic enrichment

September 4th- Dr. Raffaela Greco- High incidence of severe TA-TMA increases mortality in adult allogeneic transplant recipients: A prospective MIDAS consortium study

July 29th- Dr. Juan Carlos Hernández-Boluda- Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis

July 11th- Prof. Thomas Cluzeau- Overall Survival and Duration of Transfusion Independence for First-Line ESA-Naive Patients With Lower-Risk Myelodysplastic Syndromes Treated With Luspatercept vs Epoetin Alfa in the COMMANDS Trial

July 8th- Dr. Ofir Wolach- Trial eligibility, treatment patterns, and outcome for venetoclax-based therapy in AML: a prospective cohort study

July 3rd- Prof. Ola Landrgen- Efficacy and safety of daratumumab in intermediate/high-risk smoldering multiple myeloma: final analysis of CENTAURUS

June 18th- IACH Radio: On Air from EHA 2025 (in French)- Mohamad Mohty- Best of myélome à l'EHA 2025

June 18th- IACH Radio: On Air from EHA 2025 (in French)- Arthur Bobin- ISASOCUT

June 18th- IACH Radio: On Air from EHA 2025 (in French)- Jean-Marc Schiano- Le myélome de haut risque